Assura Plc (LON:AGR – Get Free Report) insider Jayne Cottam purchased 363 shares of Assura stock in a transaction dated Wednesday, March 5th. The shares were acquired at an average cost of GBX 41 ($0.53) per share, with a total value of £148.83 ($192.31).
Jayne Cottam also recently made the following trade(s):
- On Wednesday, February 5th, Jayne Cottam purchased 405 shares of Assura stock. The shares were acquired at an average cost of GBX 37 ($0.48) per share, with a total value of £149.85 ($193.63).
Assura Price Performance
LON AGR opened at GBX 40.74 ($0.53) on Friday. Assura Plc has a 52 week low of GBX 35.24 ($0.46) and a 52 week high of GBX 46.20 ($0.60). The firm has a market capitalization of £1.33 billion, a P/E ratio of -38.94, a PEG ratio of 3.60 and a beta of 0.37. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05. The company has a 50-day moving average price of GBX 38.69 and a 200-day moving average price of GBX 39.77.
About Assura
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Featured Stories
- Five stocks we like better than Assura
- Financial Services Stocks Investing
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Where Do I Find 52-Week Highs and Lows?
- 3 Stocks to Buy While Others Stay on the Sidelines
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.